Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05112562
Other study ID # 20.172
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 9, 2021
Est. completion date December 31, 2024

Study information

Verified date November 2022
Source University of Wisconsin, Milwaukee
Contact Seok Hyun Gwon, PhD, RN
Phone 414-229-6462
Email gwon@uwm.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aims are to (1) evaluate attentional bias to e-cigarette cues between the intervention and control groups at post-intervention as compared to the pre-intervention; and (2) test the feasibility and efficacy of the intervention at post-intervention. To accomplish these aims, a theory-driven parallel, controlled 2-arm randomized clinical trial will be conducted with young adult e-cigarette users (approximately N = 50). Outcomes are attentional bias to e-cigarette cues and abstinence outcomes including nicotine dependence, and arousal/urges for e-cigarette use.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2024
Est. primary completion date May 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 29 Years
Eligibility Inclusion Criteria: - 18 and 29 years - Those who use ENDS exclusively, not combining with other tobacco, for 3 consecutive months - Those who own a smartphone. Exclusion criteria: - Current medication or psychosocial treatment for ENDS dependence - Serious alcohol-use problems (= 26 points on the Alcohol Use Disorders Identification Test) - Ophthalmic conditions impeding eye-tracking - Current psychiatric/psychosocial treatment for other mental health disorders in the DSM-5 (e.g., schizophrenia) - Pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Computerized attentional bias modification training
In intervention is designed to train participants to disengage attention from potent e-cigarette cues and is based on the well-established attention retraining paradigm for other psychopathologies.
Placebo attention control training
This control training is very similar to the intervention's overall task structure and stimuli. The only difference is that the this control program is designed to exert no systematic manipulation on the attention deployment pattern between the two stimulus categories, thereby yielding no significant impact on the level of attentional bas toward ENDS-related cues

Locations

Country Name City State
United States University of Wisconsin-Milwaukee Milwaukee Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
University of Wisconsin, Milwaukee

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Attentional bias to e-cigarette cues measured by cueing task Attentional bias measured by time in milliseconds between cue and response in cueing task Pre-training
Primary Attentional bias to e-cigarette cues measured by cueing task Attentional bias measured by time in milliseconds between cue and response in cueing task 1-month follow up
Primary Attentional bias to e-cigarette cues measured by cueing task Attentional bias measured by time in milliseconds between cue and response in cueing task 2-months follow up
Primary Attentional bias to e-cigarette cues measured by cueing task Attentional bias measured by time in milliseconds between cue and response in cueing task 4-months follow up
Secondary Subjective urges for e-cigarette use Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire) Pre-training
Secondary Nicotine dependence Nicotine dependence measured by Penn State E-Cigarette Dependence Index Pre-training
Secondary Subjective urges for e-cigarette use Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire) 1-momnth follow up
Secondary Nicotine dependence Nicotine dependence measured by Penn State E-Cigarette Dependence Index 1-month follow up
Secondary Subjective urges for e-cigarette use Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire) 2-momnth follow up
Secondary Nicotine dependence Nicotine dependence measured by Penn State E-Cigarette Dependence Index 2-month follow up
Secondary Subjective urges for e-cigarette use Subjective urges for ENDS use measured by E-cigarette Use Patterns questionnaire) 4-momnth follow up
Secondary Nicotine dependence Nicotine dependence measured by Penn State E-Cigarette Dependence Index 4-month follow up
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06021652 - Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening N/A
Completed NCT02735382 - EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study N/A
Completed NCT02557919 - Families Reduce Exposure to Smoke at Home N/A
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Completed NCT00786149 - Improving Varenicline Adherence and Outcomes in Homeless Smokers Phase 3
Completed NCT00387946 - Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN) Phase 3
Completed NCT00218452 - Smoking Cessation for Young Adults Who Binge Drink - 1 Phase 0
Completed NCT00124683 - Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 Phase 2
Recruiting NCT04610931 - Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation N/A
Enrolling by invitation NCT06042361 - Enhancing Equity in Smoke-free Housing N/A
Recruiting NCT04827420 - Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion) N/A
Recruiting NCT04994444 - Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts Phase 2/Phase 3
Completed NCT05560243 - Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil N/A
Completed NCT02721082 - Changing the Default for Tobacco Treatment Phase 4
Completed NCT01885221 - A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree) N/A
Completed NCT03445507 - Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care. N/A
Completed NCT04540081 - Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer N/A
Completed NCT03714191 - Optimizing the Tobacco Cessation Clinical Decision Support Tool.
Completed NCT03553992 - An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers N/A
Completed NCT01699828 - Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET Phase 1/Phase 2